Home
Conditions
Neuroinflammatory Diseases

Clinical trial condition

Neuroinflammatory Diseases

Explore clinical trials studying Neuroinflammatory Diseases. Study availability and eligibility vary by location and protocol.

1,038 public trials 116 recruiting studies

Refine in advanced search Browse all conditions

Neuroinflammatory Diseases trial results

Completed

Persistence of Bactericidal Antibodies in Adults Who Received a Booster Dose of Menactra® Approximately 4 Years Earlier

NCT02633787

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +12 more
Locations: Bardstown, Kentucky, United States

Woburn, Massachusetts, United States

Niles, Michigan, United States

Layton, Utah, United States

View Trial Details

Completed

Immunogenicity and Safety of a DTPa-HBV-IPV/Hib Vaccine Given at 2, 3 and 4 Months of Age

NCT00376779

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +32 more
Locations: GSK Investigational Site Jarvenpaa, Finland

GSK Investigational Site Oulu, Finland

GSK Investigational Site Pori, Finland

GSK Investigational Site Tampere, Finland

View Trial Details

Completed

Compare Immunogenicity & Safety of 2 Formulations of GSK Biologicals' DTPa-HBV-IPV/Hib Vaccine Given in Healthy Infants

NCT00320463

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +28 more
Locations: GSK Investigational Site Murmansk, Russia

GSK Investigational Site Perm, Russia

GSK Investigational Site Syktyvkar, Russia

GSK Investigational Site Syktyvkar, Russia

View Trial Details

Completed

Pharmacological Study of High Doses of Ceftriaxone in Meningitidis

NCT01745679

Conditions: Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Meningitis, +3 more
Locations: Tours universitary hospital Tours, France

Nantes Universitary Hospital Nantes, Loire Atlantique, France

Angers Universitary Hospital Angers, France

La Roche/Yon hospital La Roche/Yon, France

View Trial Details

Completed

Immunogenicity & Safety of GSK's Combined DTPa-HBV-IPV/Hib Vaccine in Indian Infants at 2 Diff Vaccination Schedules

NCT00316147

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +36 more
Locations: GSK Investigational Site Bangalore, India

GSK Investigational Site Baroda, India

GSK Investigational Site Goā, India

GSK Investigational Site New Delhi, India

View Trial Details

Completed

Multicentre Booster & Immune Memory Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine or a Single Dose of 23-valent Plain Polysaccharide Vaccine in Healthy Children Aged 11-18 Mths, Previously Vaccinated in Study 103488

NCT00307567

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +32 more
Locations: GSK Investigational Site Bad Saulgau, Baden-Wurttemberg, Germany

GSK Investigational Site Bretten, Baden-Wurttemberg, Germany

GSK Investigational Site Eppelheim, Baden-Wurttemberg, Germany

GSK Investigational Site Kehl, Baden-Wurttemberg, Germany

View all 51 locations

View Trial Details

Completed

Retrospective Study of the Survival of Patients Suffering From Hiv-related Progressive Multifocal Leukoencephalopathy

NCT02895581

Conditions: Brain Diseases, Central Nervous System Diseases, Central Nervous System Infections, +15 more
Locations: Not specified

View Trial Details

Completed

Immunogenicity and Reactogenicity of GSK Bio DTPa-HBV-IPV and Hib Vaccines When Coadministered to Healthy Infants

NCT00879827

Conditions: Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +28 more
Locations: Not specified

View Trial Details

Completed

A Clinical Trial for Inactivated Japanese Encephalitis Vaccine in Healthy Chinese Infants

NCT02367664

Conditions: Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +16 more
Locations: Pizhou Center for Disease Control and Prevention Xuzhou, Jiangsu, China

View Trial Details

Completed

Study of Two Doses of Menactra® or One Dose of Monovalent Meningococcal Group C Vaccine With Routine Immunizations

NCT01359449

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +7 more
Locations: Pierrefonds, Quebec, Canada

View Trial Details

Neuroinflammatory Diseases

Neuroinflammatory Diseases trial results

Related conditions